Antimicrobial metabolites from the marine-derived fungus Aspergillus sp. ZZ1861

Yura Ha1, Yufang Zhou2, Mingzhu Ma2

  • 1Ocean College, Zhoushan Campus, Zhejiang University, Zhoushan, 316021, China.

Phytochemistry
|May 26, 2024
PubMed

Insights

Marine fungus Aspergillus sp. ZZ1861 yielded 46 bioactive metabolites, including eight new compounds. Several compounds showed significant antifungal and antibacterial activities against pathogens like Candida albicans and Escherichia coli.

Area of Science:

  • Marine natural products chemistry
  • Mycology
  • Medicinal chemistry

Background:

  • Fungi, particularly from the genus Aspergillus, are a rich source of novel bioactive compounds.
  • Marine-derived microorganisms offer unique chemical diversity for drug discovery.

Purpose of the Study:

  • To isolate, elucidate the structures of, and evaluate the antimicrobial potential of metabolites from the marine fungus Aspergillus sp. ZZ1861.
  • To identify new bioactive natural products for potential therapeutic applications.

Main Methods:

  • Cultivation of Aspergillus sp. ZZ1861 in solid rice and liquid potato dextrose broth media.
  • Structure determination using High-Resolution Electrospray Ionization Mass Spectrometry (HRESIMS), Nuclear Magnetic Resonance (NMR) spectral analyses, Electronic Circular Dichroism (ECD), and optical rotation calculations.
  • Antimicrobial activity assessment using Minimum Inhibitory Concentration (MIC) assays against selected pathogens.

Main Results:

  • Isolation and characterization of 46 metabolites, including eight previously undescribed compounds: Emericelactones F and G, 20R,25S-preshamixanthone, 20R,25R-preshamixanthone, phthalimidinic acid A, phthalimidinic acid B, aspergilol G, and 2-hydroxyemodic amide.
  • First report of (S)-2-(5-hydroxymethyl-2-formylpyrrol-1-yl) propionic acid lactone from a natural source and the configurations of several other compounds.
  • Phthalimidinic acid A, phthalimidinic acid B, and aspergilol G exhibited potent antifungal activity against Candida albicans (MICs 1.56–3.12 μg/mL).
  • 20R,25S-preshamixanthone showed antibacterial activity against Escherichia coli (MIC 25 μg/mL).
  • 20R,25R-preshamixanthone displayed broad-spectrum antimicrobial activity against methicillin-resistant Staphylococcus aureus, E. coli, and C. albicans (MICs 25–50 μg/mL).

Conclusions:

  • The marine-derived fungus Aspergillus sp. ZZ1861 is a prolific source of structurally diverse metabolites with significant antimicrobial properties.
  • New compounds like phthalimidinic acids A and B, aspergilol G, and 20R,25R-preshamixanthone demonstrate potential as leads for developing new antifungal and antibacterial agents.